Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Edgewise Therapeutics, Inc. (EWTX) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-36.12M |
|
-- |
|
-- |
|
$42.61M |
|
$-42.61M |
|
$6.50M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-36.12M |
|
$-42.61M |
|
$-44.25M |
|
104.94M |
|
104.94M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$603.25M |
|
$8.60M |
|
$10.08M |
|
$613.33M |
|
$20.90M |
|
-- |
|
$3.37M |
|
$24.26M |
|
$589.07M |
|
$589.07M |
|
$589.07M |
|
105.34M |
|
| Cash Flow Statement Financials | |
$-70.45M |
|
$-118.27M |
|
$190.45M |
|
$41.67M |
|
$43.40M |
|
$1.74M |
|
$16.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.87 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-70.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.13% |
|
-6.13% |
|
-5.89% |
|
-6.13% |
|
$5.59 |
|
$-0.67 |
|
$-0.67 |
|